|
* Earnings continue to trickle in, with Merck
reporting lower than expected third quarter revenue though it
beat earnings forecasts thanks to cost cuts. Its shares were
little changed in early trading.
* German business sentiment fell in October for a sixth straight
month to its lowest level in almost two years, adding to recent
concerns the largest European economy may continue to struggle
to grow.
* Sarepta Therapeutics shares fell 25.7 percent in premarket
trading after it said the U.S. Food and Drug Administration
requested additional data regarding a marketing application for
its experimental muscle disorder drug.
* Shares of Brazilian companies traded in the United States
tumbled after incumbent Dilma Rousseff won reelection in a
runoff vote, defeating centrist and market favorite Aecio Neves
by a slim margin. Petrobras ADRs <PBR.N> slumped 16.1 percent in
premarket trading and Vale <VALE.N> lost 4.9 percent.
* The S&P 500 closed its best week since January 2013 helped on
Friday by earnings from Microsoft and Procter & Gamble and as
concerns eased over the possible spread of Ebola in the United
States.
Futures snapshot at 7:34 a.m.:
* S&P 500 e-minis fell 4.25 points, or 0.22 percent, with
167,042 contracts changing hands.
* Nasdaq 100 e-minis were down 6 points, or 0.15 percent, in
volume of 25,549 contracts.
* Dow e-minis lost 21 points, or 0.13 percent, with 27,303
contracts changing hands.
(Reporting by Rodrigo Campos; Editing by Bernadette Baum)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
